Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Separation of Acute Desensitization and Long-Term Tolerance of µ-Opioid Receptors Is Determined by the Degree of C-Terminal Phosphorylation.

Arttamangkul S, Leff ER, Koita O, Birdsong WT, Williams JT.

Mol Pharmacol. 2019 Oct;96(4):505-514. doi: 10.1124/mol.119.117358. Epub 2019 Aug 5.

PMID:
31383769
2.

Cellular tolerance at the µ-opioid receptor is phosphorylation dependent.

Arttamangkul S, Heinz DA, Bunzow JR, Song X, Williams JT.

Elife. 2018 Mar 28;7. pii: e34989. doi: 10.7554/eLife.34989.

3.

Agonist Binding and Desensitization of the μ-Opioid Receptor Is Modulated by Phosphorylation of the C-Terminal Tail Domain.

Birdsong WT, Arttamangkul S, Bunzow JR, Williams JT.

Mol Pharmacol. 2015 Oct;88(4):816-24. doi: 10.1124/mol.114.097527. Epub 2015 May 1.

4.

Does PKC activation increase the homologous desensitization of μ opioid receptors?

Arttamangkul S, Birdsong W, Williams JT.

Br J Pharmacol. 2015 Jan;172(2):583-92. doi: 10.1111/bph.12712. Epub 2014 Jul 1.

5.

Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure.

Birdsong WT, Arttamangkul S, Clark MJ, Cheng K, Rice KC, Traynor JR, Williams JT.

J Neurosci. 2013 Feb 27;33(9):4118-27. doi: 10.1523/JNEUROSCI.4187-12.2013.

6.

Pain-facilitating medullary neurons contribute to opioid-induced respiratory depression.

Phillips RS, Cleary DR, Nalwalk JW, Arttamangkul S, Hough LB, Heinricher MM.

J Neurophysiol. 2012 Nov;108(9):2393-404. doi: 10.1152/jn.00563.2012. Epub 2012 Sep 5.

7.

Desensitization and trafficking of μ-opioid receptors in locus ceruleus neurons: modulation by kinases.

Arttamangkul S, Lau EK, Lu HW, Williams JT.

Mol Pharmacol. 2012 Mar;81(3):348-55. doi: 10.1124/mol.111.076208. Epub 2011 Nov 23.

8.

Opioid receptor internalization contributes to dermorphin-mediated antinociception.

Macey TA, Ingram SL, Bobeck EN, Hegarty DM, Aicher SA, Arttamangkul S, Morgan MM.

Neuroscience. 2010 Jun 30;168(2):543-50. doi: 10.1016/j.neuroscience.2010.04.003. Epub 2010 Apr 13.

9.

Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization.

Virk MS, Arttamangkul S, Birdsong WT, Williams JT.

J Neurosci. 2009 Jun 3;29(22):7341-8. doi: 10.1523/JNEUROSCI.3723-08.2009.

10.

Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons.

Yu YJ, Arttamangkul S, Evans CJ, Williams JT, von Zastrow M.

J Neurosci. 2009 Jan 7;29(1):222-33. doi: 10.1523/JNEUROSCI.4315-08.2009.

11.

Differential activation and trafficking of micro-opioid receptors in brain slices.

Arttamangkul S, Quillinan N, Low MJ, von Zastrow M, Pintar J, Williams JT.

Mol Pharmacol. 2008 Oct;74(4):972-9. doi: 10.1124/mol.108.048512. Epub 2008 Jul 8.

12.

Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine.

Reese EA, Bunzow JR, Arttamangkul S, Sonders MS, Grandy DK.

J Pharmacol Exp Ther. 2007 Apr;321(1):178-86. Epub 2007 Jan 11.

PMID:
17218486
13.

Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures.

Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, Williams JT.

J Neurosci. 2006 Apr 12;26(15):4118-25.

14.

mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization.

Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, Von Zastrow M, Grandy DK, Williams JT.

J Neurosci. 2002 Jul 1;22(13):5769-76.

15.

A RAVE about opioid withdrawal.

Alvarez V, Arttamangkul S, Williams JT.

Neuron. 2001 Dec 6;32(5):761-3. Review.

16.

Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK.

Mol Pharmacol. 2001 Dec;60(6):1181-8.

PMID:
11723224
17.

Binding and internalization of fluorescent opioid peptide conjugates in living cells.

Arttamangkul S, Alvarez-Maubecin V, Thomas G, Williams JT, Grandy DK.

Mol Pharmacol. 2000 Dec;58(6):1570-80.

PMID:
11093798
18.

Integrity of tritiated orphanin FQ/nociceptin: implications for establishing a reliable binding assay.

Quigley DI, Arttamangkul S, Allen RG, Grandy DK.

Peptides. 2000 Jul;21(7):1111-8.

PMID:
10998545
19.

Probing the cathepsin D using a BODIPY FL-pepstatin A: applications in fluorescence polarization and microscopy.

Chen CS, Chen WN, Zhou M, Arttamangkul S, Haugland RP.

J Biochem Biophys Methods. 2000 Mar 16;42(3):137-51.

PMID:
10737220
20.

5-(Pentafluorobenzoylamino)fluorescein: A selective substrate for the determination of glutathione concentration and glutathione S-transferase activity.

Arttamangkul S, Bhalgat MK, Haugland RP, Diwu Z, Liu J, Klaubert DH, Haugland RP.

Anal Biochem. 1999 May 1;269(2):410-7.

PMID:
10222018
22.

Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.

Arttamangkul S, Ishmael JE, Murray TF, Grandy DK, DeLander GE, Kieffer BL, Aldrich JV.

J Med Chem. 1997 Apr 11;40(8):1211-8.

PMID:
9111295
23.

Texas Res-X and rhodamine Red-X, new derivatives of sulforhodamine 101 and lissamine rhodamine B with improved labeling and fluorescence properties.

Lefevre C, Kang HC, Haugland RP, Malekzadeh N, Arttamangkul S, Haugland RP.

Bioconjug Chem. 1996 Jul-Aug;7(4):482-9.

PMID:
8853462
24.

Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.

Arttamangkul S, Murray TF, DeLander GE, Aldrich JV.

J Med Chem. 1995 Jun 23;38(13):2410-7.

PMID:
7608905

Supplemental Content

Loading ...
Support Center